Purpose of Review A gap exists between PrEP interest and PrEP uptake in key populations
(KP) for HIV prevention that may be ascribed to PrEP delivery services not being acceptable …

Abstract Background and Objective Best–worst scaling is a theory-driven method that can be
used to prioritize objects in health. We sought to characterize all studies of best–worst …

Women need multipurpose prevention technologies (MPTs) to simultaneously prevent
sexually transmitted infections (STIs), including HIV, with or without contraception. User …

Abstract Background and Objective Although HIV prevention science has advanced over the
last four decades, evidence suggests that prevention technologies do not always reach their …

Background Men who have sex with men (MSM) and transgender women (TGW) are
disproportionally affected by HIV infection in Latin America. This study aims to assess pre …

One hope surrounding long-acting HIV pre-exposure prophylaxis (PrEP) is reaching new
users who could most benefit, as well as improving the experiences of oral PrEP users who …

Cabotegravir long-acting injectable HIV pre-exposure prophylaxis (LA PrEP) is efficacious,
with a good safety profile, and was approved by the US Food and Drug Administration in …

Introduction Pre-exposure prophylaxis (PrEP) is an important and well-established
prevention strategy for sexual acquisition of HIV. In Brazil, transgender women (TGW) and …

User costs constitute a barrier to the uptake of HIV pre-exposure prophylaxis (PrEP), but
their magnitude appears rarely assessed. In this prospective observational study, we …

Introduction Pre-exposure prophylaxis (PrEP) is highly effective at preventing HIV
acquisition, but coverage remains low in high prevalence settings. Initiating and continuing …